SANDERLING VENTURES MANAGEMENT V
CIK 1267980 · last filed 2013-05-28
SANDERLING VENTURES MANAGEMENT V is a corporate insider who has filed 7 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for CMRX, was dated May 28, 2013. Across all open-market trades the lifetime net is −$160.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $341.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$341.8K
3
7
-$160.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHIMERIX INC (CMRX) Delisted | 10%+ Owner | 4,255,826 | $8.54 | $36.34M | $0 | 1 | 2013-05-28 |
| ENDOCYTE INC (ECYT) Delisted | 10%+ Owner | 32,355 | — | — | $877.6K | 5 | 2012-12-12 |
| BEAT | 10%+ Owner | 451,045 | $0.76 | $341.8K | -$161.77M | 1 | 2008-08-08 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-28 | CHIMERIX INC (CMRX) Delisted | Conv (C) | +7,920,370 | $0 | EDGAR |
| 2012-12-12 | ENDOCYTE INC (ECYT) Delisted | Buy (P) | +6,356 | $20.2K | EDGAR |
| 2012-01-11 | ENDOCYTE INC (ECYT) Delisted | Buy (P) | +88,800 | $282.4K | EDGAR |
| 2011-03-09 | ENDOCYTE INC (ECYT) Delisted | Conv (C) | +34,636 | $0 | EDGAR |
| 2011-02-11 | ENDOCYTE INC (ECYT) Delisted | Conv (C) | +96,168 | $0 | EDGAR |
| 2011-02-08 | ENDOCYTE INC (ECYT) Delisted | Buy (P) | +95,832 | $575.0K | EDGAR |
| 2008-08-08 | BEAT | Sell (S) | −6,104,440 | -$161.77M | EDGAR |